Showing results (571-580 of 659) with videos related to
Sort By:
Pageof 66
The British Journal of Radiology|December 15, 2012
Grey-scale inversion improves detection of lung nodulesJ W Robinson, J T Ryan, M F McEntee, et al.Medical Mycology|December 5, 2002
Effect of CD40 ligand on the course of murine histoplasmosisL J Wheat, M Durkin, C Schnizlein-Bick, et al.Archives Italiennes De Biologie|July 13, 2012
Chronic ramelteon treatment in a mouse model of Alzheimer's diseaseJames Timothy McKenna, Michael A Christie, Brianne A Jeffrey, et al.European Journal of Clinical Nutrition|January 9, 2014
Maternal iron levels early in pregnancy are not associated with offspring IQ score at age 8, findings from a Mendelian randomization studyS J Lewis, C Bonilla, M-J Brion, et al.Neuro-Oncology|March 6, 2013
Involved field radiation therapy after surgical resection of solitary brain metastases--mature resultsEileen P Connolly, Maya Mathew, Moses Tam, et al.BMJ Open|May 8, 2024
Identifying factors that can be used to assess a country's readiness to deploy a new vaccine or improve uptake of an underutilised vaccine: a scoping reviewAomesh Bhatt, Vaneesha Monk, Alexandra Bhatti, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 10, 2017
Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomasAniket S Wadajkar, Jimena G Dancy, Nathan B Roberts, et al.Irish Journal of Medical Science|August 8, 2020
HepCare Ireland-a service innovation projectStephen P Connolly, Gordana Avramovic, Walter Cullen, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force ReportJosephine Mauskopf, Baudouin Standaert, Mark P Connolly, et al.Oncogene|August 25, 2015
The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeuticsJ G Perez, N L Tran, M G Rosenblum, et al.Pageof 66